In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 25th, 2008 | 25 | Yes |
Popular Name: 2-phenyl-2-(2-pyridyl)imidazolidine 2-phenyl-2-(2-pyridyl)imidazolidine
Find On: PubMed — Wikipedia — Google
CAS Number: 219658-25-0
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.20 | 8.1 | -20.56 | 4 | 7 | 0 | 106 | 336.399 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 5530 | 0.29 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8000 | 0.29 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3710 | 0.30 | Binding ≤ 10μM |
FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3710 | 0.30 | Binding ≤ 10μM |
FGFR4-1-E | Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3710 | 0.30 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4670 | 0.30 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4670 | 0.30 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 5530 | 0.29 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 3700 | 0.30 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 3710 | 0.30 | Binding ≤ 10μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 3710 | 0.30 | Binding ≤ 10μM |
FGFR4_HUMAN | P22455 | Fibroblast Growth Factor Receptor 4, Human | 3710 | 0.30 | Binding ≤ 10μM |
PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 4670 | 0.30 | Binding ≤ 10μM |
PGFRB_MOUSE | P05622 | Platelet-derived Growth Factor Receptor Beta, Mouse | 4700 | 0.30 | Binding ≤ 10μM |
PGFRB_RAT | Q05030 | Platelet-derived Growth Factor Receptor Beta, Rat | 4670 | 0.30 | Binding ≤ 10μM |
Description | Species |
---|---|
Activated point mutants of FGFR2 | |
betaKlotho-mediated ligand binding | |
Constitutive PI3K/AKT Signaling in Cancer | |
Downstream signal transduction | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
FGFR4 ligand binding and activation | |
FRS2-mediated cascade | |
GAB1 signalosome | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Negative regulation of FGFR signaling | |
Phospholipase C-mediated cascade | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
SHC-mediated cascade | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by activated point mutants of FGFR1 | |
Signaling by activated point mutants of FGFR3 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by FGFR3 mutants | |
Signaling by FGFR4 mutants | |
Signaling by PDGF | |
t(4;14) translocations of FGFR3 |